The effect of NSC348884 in AML was analysed by comparing cells expressing NPM1c+ (OCI-AML3) and cells expressing only wild type NPM1 (HL-60 and OCI-AML2) [86]. This evidence concerns the gene RUNX2 and acute myeloid leukemia.